Searchable abstracts of presentations at key conferences in endocrinology

ea0081oc2.5 | Oral Communications 2: Adrenal and Cardiovascular Endocrinology 1 | ECE2022

Elevated serum free cortisol is a strong predictor of mortality in hospitalized patients with Covid-19 irrespective of dexamethasone treatment

Rozenfeld Karina , Izkhakov Elena , Moshiashvili Miguel , Oster Howard , Tordjman Karen , Shefer Gabi , Greenman Yona

Serum total cortisol has been linked to increased mortality in patients with Covid-19, but its reliability in critically ill patients is limited. We examined the association between serum free cortisol (SFC) levels and clinical outcomes in patients hospitalized with Covid-19 between 5/5/2020 and 1/3/2021 in our institution. Methods: SFC was measured in blood samples collected at patient’s admission, prior to any medical treatment. Patients’ fil...

ea0041ep1090 | Thyroid cancer | ECE2016

Differential expression of mRNA of the vitamin D receptor, 1α-hydroxylase 25-hydroxy vitamin D and estrogen receptors in human explants and cell cultures of thyroid cancer and normal tissues

Somjen Dalia , Sharon Orli , Knoll Esther , Aizic Abraham , Fliss David , Limor Rona , Stern Naftali , Izkhakov Elena

Several studies indicated that estrogen receptors (ERs) and vitamin D receptor (VDR), as well 1α-hydroxylase 25-hydroxy vitamin D (1OHase) are expressed in various normal and cancerous cell types. To date, there are no reported studies on the different expressions of VDR, 1OHase and ERs, in human thyroid normal and cancer cells. This study addresses these questions. Tissues harvested from papillary thyroid cancer (PTC) and normal glands explants were used throughout eithe...

ea0081p721 | Thyroid | ECE2022

Does the risk of new metabolic changes among thyroid cancer survivors depend upon thyroid function?

Izkhakov Elena , Shacham Yacov , Ziv-Baran Tomer , Yaish Iris , Horowitz Gilad , Warshavsky Anton , Muhanna Nidal , Nard Carmel-Neidermann Narin , Tordjman Karen , Greenman Yona

Background: Various components of metabolic syndrome (MS) significantly increase the risk of thyroid cancer (TC). Moreover, thyroid cancer survivors (TCS) are at increased risk of new components of MS (MSC). The role of thyroid function in this context has not yet been determined. We investigated changes in selected MSC and their association with thyroid function during a two-year follow-up among TCS.Materials and Methods: This retrospective, nested case...